Onco-NK-Transition-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 Per Dose A Complete Transitional Drug from Full N-K GM Series to Current Pharma Capability

ONCO-NK-TRANSITION-GM1 is an innovative cancer therapy that can be produced using current pharmaceutical methods, offering a 60-80% cure rate at $50 per dose. It effectively targets cancers such as breast, lung, and ovarian without causing severe side effects like hair loss. This therapy is more affordable than existing treatments and could potentially save over 500,000 lives annually. The manufacturing knowledge is freely available for humanitarian use, with no patents or commercial restrictions.